INS and metabolic disease: Another in vivo study revealed that diet supplementation with butyrate mitigated metabolic disorder and intestinal epithelial impairment in type 2 diabetic mice by promoting the secretion of insulin without compensatory hyperplasia in pancreatic β cells [89].